ADENOVIRUS IL-12 AND DOCETAXEL IN COMBINATION WITH ANTI-PD1 AS AN EFFECTIVE TREATMENT STRATEGY FOR TNBC

被引：0
|
作者：
Qian, Wei [1 ]
Zhou, Jianying [1 ]
Rosato, Roberto [1 ]
Chang, Jenny [1 ]
Anselme, Ann [1 ]
机构：
[1] Houston Methodist Res Inst, Houston, TX USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0437
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
437
引用
收藏
页码：A266 / A266
页数：1
相关论文
共 50 条
  • [41] Treatment of experimental breast cancer with combination of IL-12 gene therapy and anti-VEGFR-2 antibody
    Rakhmilevich, AL
    Hooper, AT
    Imboden, M
    Hicklin, DJ
    Sondel, PM
    CANCER GENE THERAPY, 2003, 10 : S38 - S38
  • [42] Telomerase-specific oncolytic adenovirus amplifies immunogenic effects with anti-PD1 antibody
    Hashimoto, Masashi
    Kuroda, Shinji
    Kanaya, Nobuhiko
    Yagi, Chiaki
    Tsumura, Tomoko
    Kumon, Kento
    Kakiuchi, Yoshihiko
    Kikuchi, Satoru
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Mizuguchi, Hiroyuki
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2021, 112 : 399 - 399
  • [43] Pre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy
    Lee, J. H.
    Lim, S. Y.
    Menzies, A. M.
    Carlino, M. S.
    Guminski, A.
    Nahar, K.
    Palmieri, D.
    Breen, E.
    Kefford, R.
    Scolyer, R.
    Long, G. V.
    Rizos, H.
    ANNALS OF ONCOLOGY, 2018, 29 : 659 - 659
  • [44] High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma
    Burkard, Markus
    Niessner, Heike
    Leischner, Christian
    Piotrowsky, Alban
    Renner, Olga
    Marongiu, Luigi
    Lauer, Ulrich M.
    Busch, Christian
    Sinnberg, Tobias
    Venturelli, Sascha
    CELLS, 2023, 12 (02)
  • [45] Regulated Expression of IL-12 as Gene Therapy Concomitant with Blockade of PD-1 for Treatment of Glioma
    Barrett, John A.
    Cai, Hongliang
    Miao, John
    Murray, Margaret
    Gonzales, Paul
    Krishnan, Suma
    Lebel, Francois
    Cooper, Laurence J. N.
    MOLECULAR THERAPY, 2016, 24 : S203 - S203
  • [46] Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
    Fujita, Kohei
    Terashima, Tsuyoshi
    Mio, Tadashi
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (12) : 2238 - 2240
  • [47] IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice
    Harada, N
    Shimada, M
    Okano, S
    Suehiro, T
    Soejima, Y
    Tomita, Y
    Maehara, Y
    JOURNAL OF IMMUNOLOGY, 2004, 173 (11): : 6635 - 6644
  • [48] Dermatologic adverse events during treatment with anti-PD1 inhibitors
    Benhuri, Benjamin
    Belum, V. R.
    Lacouture, Mario
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB116 - AB116
  • [49] FINAL RESULTS OF CONTROLLED IL-12 MONOTHERAPY AND IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA
    Lukas, Rimas
    Oberheim-Bush, Nancy Ann
    Cavaliere, Robert
    Landolfi, Joseph
    Yu, John S.
    Chen, Clark
    Cordova, Christine
    Amidei, Christina
    Buck, Jill Y.
    Hadar, Nira
    Demars, Nate
    Miao, John
    John, Loewy John
    Estupinan, Taylor
    Chadha, Kamal
    Cooper, Laurence J. N.
    Chiocca, E. Antonio
    NEURO-ONCOLOGY, 2021, 23 : 54 - 54
  • [50] Evaluation of ENMD-2076 in combination with anti-PD1 in syngeneic cancer models
    Fletcher, Graham C.
    Kiarash, Reza
    Bray, Mark R.
    Hu, Amanda S.
    Ren, Ken K.
    CANCER RESEARCH, 2017, 77
12345